Evaluating Pelvic Floor Therapy to Treat Erectile Dysfunction and Premature Ejaculation in Men

What this Trial Is About

This research aims to evaluate the effectiveness of pelvic floor therapy in managing erectile dysfunction and premature ejaculation among men experiencing these conditions. The study focuses on whether pelvic floor therapy, which includes electrostimulation, biofeedback, and therapeutic exercise, can improve erectile function and intravaginal latency time in three distinct patient groups those with premature ejaculation, erectile dysfunction, and both conditions combined. Participants will receive 24 sessions of pelvic floor therapy over 12 weeks. The therapy varies depending on whether the patient has muscular hyperactivity or hypoactivity and includes therapeutic exercises, perineal electromyographic biofeedback, and electrical stimulation. The sessions involve assessments, proprioceptive and coordination work, muscle workouts, functional training, and a final evaluation. During the study, participants will have initial and secondary pelvic floor rehabilitation consultations. Outcomes such as changes in intravaginal latency time and erectile function scores will be measured at 12 weeks, with follow-up assessments at 3 and 6 months. Researchers will also monitor side effects and other related scores throughout the study period, ensuring comprehensive evaluation of therapy impact over time.

Effectiveness of Pelvic Floor Therapy for the Management of Erectile Dysfunction and Premature Ejaculation.